Amelioration of Sensory Nerve Dysfunction by C-Peptide in Patients With Type 1 Diabetes

Diabetes- United States

doi 10.2337/diabetes.52.2.536

Full Text

Abstract

Available in

Date

Authors

Publisher

American Diabetes Association

Related search

Increased Interleukin-35 Levels in Patients With Type 1 Diabetes With Remaining C-Peptide

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2017English

C-Peptide Reverses Nociceptive Neuropathy in Type 1 Diabetes

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2006English

Thyroid Dysfunction in Patients With Type 1 Diabetes: A Longitudinal Study

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2003English

The Clinical Potential of C-Peptide Replacement in Type 1 Diabetes

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2012English

Prevalence of Subclinical Peripheral Neuropathy by Nerve Conduction Study in Patients With Type 1 Diabetes Mellitus

Journal of Evidence Based Medicine and Healthcare
2019English

C-Peptide Exerts Beneficial Effects on Myocardial Blood Flow and Function in Patients With Type 1 Diabetes

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2002English

Residual C-Peptide Secretion and Endothelial Function in Patients With Type II Diabetes

Clinical Science
Medicine
2003English

C-Peptide Persistence in Type 1 Diabetes: ‘Not Drowning, but Waving’?

BMC Medicine
Medicine
2019English

Pregnancy-Induced Rise in Serum C-Peptide Concentrations in Women With Type 1 Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy